Community/Retail

This article describes a purposed method for implementation and expansion of a bedside medication delivery program. Although no two programs will be alike, this article will assist in guiding pharmacists and pharmacy departments wishing to expand their pharmacy services to include a bedside delivery program.

The American Pharmacists Association (APhA) will host its 4th Annual Capitol Hill Health Fair on September 22 as part of its advocacy and community outreach efforts in advance of American Pharmacists Month.

A number of manufacturers are developing drugs to treat NASH, and approximately 95 drugs are in the pipeline worldwide at various stages of development.

Although we can all agree that failure is something we simply must endure at some point, it continues to be a taboo topic in academic culture.

The FDA has approved 14 disease-modifying medications for use in relapsing forms of multiple sclerosis.

FLAVORx Helps Retail Partners Improve the Pharmacy Experience by Personalizing Medication for Young Children

When it comes to influenza treatment, oseltamivir is often the first medication considered, but could peramivir be an alternative in inpatient settings?

Pharmacists should know about the rising popularity of carfentanil, a drug more powerful than fentanyl and often so potent that one dose of naloxone isn't enough to reverse an overdose.

How micronutrients affect adenocarcinoma of the prostate has been long debated.

To date, medication therapy management and annual wellness visits are the primary services that have demonstrated benefits regarding improvements in health outcomes and cost savings when pharmacists are integrated specifically within an ACO.

Little else you'll do in your pharmacy business will be so fruitful as hiring the right individual, and little else will be so damaging as hiring the wrong one.

I recently attended the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences held in Buenos Aires, Argentina.

The American Pharmacists Association (APhA) is furthering its support of global improvements in patient care through volunteer leadership.

Seventh Annual Lecture to Be Presented September 20.

Physical textbooks continue to plague many pharmacy students.

Prescription opioid pain medications like hydrocodone, oxycodone, and morphine can elicit similar effects to heroin when taken incorrectly and at higher doses than prescribed.

If we can pull components of a combo meal by assembly line, why can't we do the same with simple pharmacy orders?

It's astonishing to think a stroke can occur at any time and possibly leave an individual disabled for the rest of his or her life.

From October 15-19, thousands of pharmacists from around the world will gather in New Orleans for NCPA's Annual Convention.

The Rite Aid Foundation has announced that more than 400 students have been named recipients of Folds of Honor educational scholarships through its KidCents program.

CVS Health today announced that it has partnered with the YMCA of the USA to help expand two programs that provide critical support to people across the country.

Erin L. Albert, MBA, PharmD, JD, weaves together the full recap of all 5 parts of the series with special questions from our valued listeners directed at our series participants.

A new Government Accountability Office (GAO) report finds that prices for generic drugs in Medicare Part D fell 59% from the first quarter of 2010 to the second quarter of 2015.

Four U.S. Senators today introduced bipartisan legislation to boost transparency in Medicare Part D drug spending and to prohibit retroactive "DIR fees" in response to concerns raised by National Community Pharmacists Association (NCPA) members and staff.

Although America's uninsured rate has fallen to a historic low, cost and quality of health care seems to fluctuate from state to state.

Health care professionals are increasingly confronted with incorporating dietary supplements many of which are prescribed by clinicians for a wide range of conditions into their care plans.

The FDA has expanded the use of Amgen's blinatumomab (Blincyto) to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in pediatric patients.